Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 12, 2016 5:36 AM ET


Company Overview of TEI Biosciences Inc.

Company Overview

TEI Biosciences Inc., a biomedical company, develops, manufactures, markets, and sells biologic devices for the repair, reinforcement, or reconstruction of human tissues that have failed due to aging, injury, or disease in the United States and internationally. The company offers its biologic devices for soft tissue repair and regenerative applications, including dura and hernia repair, and plastic and reconstructive surgery. Its products include SurgiMend, a cellular collagen matrix derived from fetal and neonatal bovine dermis; SurgiMend-e, a family of collagen matrices for soft tissue reconstruction; SurgiMend PRS, a acellular biologic matrix designed for plastic and reconstructive surger...

1000 Winter Street

Waltham, MA 02451

United States

Founded in 1993





Key Executives for TEI Biosciences Inc.

Chairman, Chief Executive Officer and President
Age: 54
Director of Finance
Vice President of Product Sciences and Regulatory Affairs
Vice President of Manufacturing and Quality
Director of Manufacturing
Compensation as of Fiscal Year 2015.

TEI Biosciences Inc. Key Developments

Integra LifeSciences Holdings Corporation, TEI Biosciences Inc., TEI Medical Inc. - M&A Call

To discuss definitive agreement under which Integra will acquire all of the outstanding shares of TEI Biosciences, Inc. and TEI Medical, Inc

TEI Biosciences Receives Contract from Health Resource Services

TEI Biosciences Inc. announced that it has signed an agreement with Health Resource Services, LLC (HRS) for its SurgiMendĀ® Collagen Matrix for Soft Tissue Reconstruction. The three year agreement is effective May 1, 2015 and will make SurgiMend available to the HRS network, which includes over 150 acute care and teaching hospitals in more than 20 states throughout the country.

TEI Biosciences Inc. Receives Major Contract with Novation

TEI Biosciences Inc. announced that it has signed a national agreement with Novation. The three-year contract begins April 1st, 2015, and will make TEI's biologic mesh available to more than 100,000 members and affiliates of VHA Inc., UHC, Children's Hospital Association and Provista LLC.

Similar Private Companies By Industry

Company Name Region
DynPort Vaccine Company LLC United States
Escape Therapeutics, Inc. United States
Pivotal BioSciences, Inc. United States
Alopexx Pharmaceuticals, LLC United States
Sirtex Medical Inc. United States

Recent Private Companies Transactions

June 28, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TEI Biosciences Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at